Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis

S. Vosslamber; L.F. van der Voort; I.J. van den Elskamp; R Heijmans; C. Aubin; B.M.J. Uitdehaag; J.B.A. Crusius; T.C.T.M. van der Pouw Kraan; M. Comabella; X. Montalban; D.A. Hafler; P.L. Jager; J. Killestein; C.H. Polman; C.L. Verweij

doi:https://doi.org/10.1038/gene.2011.18

Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis

S. Vosslamber, L.F. van der Voort, I.J. van den Elskamp, R Heijmans, C. Aubin, B.M.J. Uitdehaag, J.B.A. Crusius, T.C.T.M. van der Pouw Kraan, M. Comabella, X. Montalban, D.A. Hafler, P.L. Jager, J. Killestein, C.H. Polman, C.L. Verweij

Research output: Contribution to journal › Article › Academic › peer-review

32 Citations (Scopus)

Original language	English
Pages (from-to)	466-472
Journal	Genes and immunity
Volume	12
Issue number	6
DOIs	https://doi.org/10.1038/gene.2011.18
Publication status	Published - 2011

Access to Document

https://doi.org/10.1038/gene.2011.18

Cite this

Vosslamber, S., van der Voort, L. F., van den Elskamp, I. J., Heijmans, R., Aubin, C., Uitdehaag, B. M. J., Crusius, J. B. A., van der Pouw Kraan, T. C. T. M., Comabella, M., Montalban, X., Hafler, D. A., Jager, P. L., Killestein, J., Polman, C. H., & Verweij, C. L. (2011). Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis. Genes and immunity, 12(6), 466-472. https://doi.org/10.1038/gene.2011.18

@article{39d5a274fef944b4ab578fcf4ba81161,

title = "Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis",

author = "S. Vosslamber and {van der Voort}, L.F. and {van den Elskamp}, I.J. and R Heijmans and C. Aubin and B.M.J. Uitdehaag and J.B.A. Crusius and {van der Pouw Kraan}, T.C.T.M. and M. Comabella and X. Montalban and D.A. Hafler and P.L. Jager and J. Killestein and C.H. Polman and C.L. Verweij",

year = "2011",

doi = "https://doi.org/10.1038/gene.2011.18",

language = "English",

volume = "12",

pages = "466--472",

journal = "Genes and immunity",

issn = "1466-4879",

publisher = "Nature Publishing Group",

number = "6",

}

Vosslamber, S, van der Voort, LF, van den Elskamp, IJ, Heijmans, R, Aubin, C, Uitdehaag, BMJ, Crusius, JBA, van der Pouw Kraan, TCTM, Comabella, M, Montalban, X, Hafler, DA, Jager, PL, Killestein, J , Polman, CH & Verweij, CL 2011, 'Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis', Genes and immunity, vol. 12, no. 6, pp. 466-472. https://doi.org/10.1038/gene.2011.18

TY - JOUR

T1 - Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis

AU - Vosslamber, S.

AU - van der Voort, L.F.

AU - van den Elskamp, I.J.

AU - Heijmans, R

AU - Aubin, C.

AU - Uitdehaag, B.M.J.

AU - Crusius, J.B.A.

AU - van der Pouw Kraan, T.C.T.M.

AU - Comabella, M.

AU - Montalban, X.

AU - Hafler, D.A.

AU - Jager, P.L.

AU - Killestein, J.

AU - Polman, C.H.

AU - Verweij, C.L.

PY - 2011

Y1 - 2011

U2 - https://doi.org/10.1038/gene.2011.18

DO - https://doi.org/10.1038/gene.2011.18

M3 - Article

C2 - 21471993

SN - 1466-4879

VL - 12

SP - 466

EP - 472

JO - Genes and immunity

JF - Genes and immunity

IS - 6

ER -